First-Line Treatment of Acute Esophageal Variceal Bleeding

Acute esophageal variceal bleeding is a time-critical emergency. Prompt, coordinated intervention is required to arrest haemorrhage and restore haemodynamic stability before further complications develop.

Treatment Approach

The first-line strategy combines vasoactive pharmacotherapy, started as early as possible after the index bleed, with endoscopic intervention performed urgently. Antibiotic prophylaxis and transfusion management are integral parts of the regimen. The complete sequence, agent selection, timing, and thresholds are specified in the full protocol.

Clinical Goal

Treatment success is defined as control of acute variceal bleeding: cessation of haemorrhage with haemodynamic stability sustained for at least 48 hours after therapy.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1007/s12072-025-10894-4

Combination of a vasoactive drug and endoscopic therapy is the first-line therapy for acute variceal bleed.
Vasoactive treatment should be started at the earliest, preferably within 30 minutes of index bleed.
Band ligation with multi-band ligator is the preferred modality of therapy for esophageal variceal bleed.
Control of AVB is defined as the cessation of bleeding with hemodynamic stability (systolic blood pressure > 90 mmHg and MAP ≥ 60 mmHg) for at least 48 h post-therapy.

View source ↗